Chempartner Pharmatech Co Ltd Class A 300149
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥5.90
- Day Range
- ¥5.83–6.40
- 52-Week Range
- ¥3.68–9.30
- Bid/Ask
- ¥6.08 / ¥6.09
- Market Cap
- ¥3.04 Bil
- Volume/Avg
- 65.6 Mil / 24.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.76
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Chempartner Pharmatech Co Ltd is engaged in the research, development, production, and operation of prebiotics, micro-ecological medical, and biopharmaceuticals.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,916
- Website
- https://www.cppt.com.cn
Comparables
Valuation
|
Metric
|
300149
|
301207
|
300122
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 15.59 | 11.23 |
Price/Book Value | 2.17 | 1.84 | 2.11 |
Price/Sales | 2.76 | 4.74 | 1.43 |
Price/Cash Flow | 22.49 | 11.51 | 9.26 |
Price/Earnings
300149
301207
300122
Financial Strength
|
Metric
|
300149
|
301207
|
300122
|
|---|---|---|---|
Quick Ratio | 1.46 | 2.85 | 1.37 |
Current Ratio | 1.71 | 3.42 | 2.07 |
Interest Coverage | −32.05 | 149.96 | 76.85 |
Quick Ratio
300149
301207
300122
Profitability
|
Metric
|
300149
|
301207
|
300122
|
|---|---|---|---|
Return on Assets (Normalized) | −34.73% | 9.24% | 11.64% |
Return on Equity (Normalized) | −54.47% | 11.52% | 19.62% |
Return on Invested Capital (Normalized) | −38.80% | 10.82% | 17.67% |
Return on Assets
300149
301207
300122
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Fpmqmrgn | Frs | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Wsdsztrz | Ysfvrg | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Nkkvtdvg | Mnnfzs | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Mxbllxxx | Mcgnky | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Rgqpphkck | Vjp | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Jtsnlfpfc | Htqvc | $28.1 Bil | |||
| Moderna Inc
MRNA
| Wvszhfnrg | Lqsc | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Rxpptctz | Vcnr | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Sljkykv | Bclnj | $13.4 Bil | |||
| Incyte Corp
INCY
| Mpnkqcpm | Xfftzd | $12.7 Bil |
United States